PKM and cancer: These pathways synergistically upregulate glucose transporter and glycolytic enzyme expression, driving cancer cell metabolic reprogramming.145 The metabolic network’s core effector molecules focus on three critical rate-limiting enzymes: hexokinase 2 (HK2), phosphofructokinase-1 (PFK-1), and pyruvate kinase M2 (PKM2).